Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The Food and Drug Administration
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The Food and Drug Administration
Incannex Healthcare Inc. (Nasdaq: IXHL), (‘Incannex’ or the ‘Company’), a pharmaceutical company developing unique medicinal cannabinoid pharmacotherapies and psychedelic medicine therapies is pleased to announce that
To date, MAPS has supported nearly 70 organizations worldwide to advance charitable projects in the psychedelic movement Currently, MAPS serves as a fiscal sponsor for
FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (“FSD Pharma” or the “Company“), is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions. The
Share this article Daiichi was ordered to pay 8% royalty fees on Enhertu through the patent expiration date in 2024. Credits: Witthaya Prasongsin/gettyimages.com Daiichi Sankyo
Share this article Digital solutions are increasingly becoming integrated into healthcare, including mental health apps. Credit: Stokkete via Shutterstock. Telemedicine refers to the use of
Researchers investigated the relationship between early-life gut virome, specifically temperate phage taxa, and the development of asthma in childhood while considering the interaction with host
Share this article Dr. Tedros Adhanom Ghebreyesus was speaking at a panel discussing how healthcare systems should prepare for “Disease X”, at the ongoing World
Venture capital firm General Catalyst has agreed to acquire Ohio-based nonprofit health system Summa Health and reestablish it as a for-profit organization, the health system’s